Monoclonal gammopathy of undetermined significance: A primary care guide | Cleveland Clinic Journal of Medicine
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials | PLOS ONE
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
Serum Free Light Chains Blood Test
Manni Mohyuddin on Twitter: "There were some simplifications here in this thread, but will be helpful for fellows interpreting these values, and for non-hematologists who place these consults! Thanks for reading, and